These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30877856)

  • 1. Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting.
    Crépeau-Gendron G; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Veinish S; Mah L
    J Affect Disord; 2019 May; 250():341-345. PubMed ID: 30877856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A question about the potential cardiac toxicity of escitalopram.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
    Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.
    Kumar Y; Kung S; Shinozaki G
    J Psychopharmacol; 2014 Dec; 28(12):1143-8. PubMed ID: 25122046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should We be Worried About QTc Prolongation Using Citalopram? A Review.
    Hutton LMJ; Cave AJ; St-Jean R; Banh HL
    J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of relationship between plasma levels of escitalopram and QTc-interval length.
    Carceller-Sindreu M; de Diego-Adeliño J; Portella MJ; Garcia-Moll X; Figueras M; Fernandez-Vidal A; Queraltó JM; Puigdemont D; Álvarez E
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):815-822. PubMed ID: 28116499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT; Lee Y; Lin YE; Lin PY
    Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.
    Do A; Noohi S; Elie D; Mahdanian AA; Yu C; Segal M; Looper KJ; Rej S
    Psychosomatics; 2016; 57(1):57-63. PubMed ID: 26633294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT interval and antidepressant use: a cross sectional study of electronic health records.
    Castro VM; Clements CC; Murphy SN; Gainer VS; Fava M; Weilburg JB; Erb JL; Churchill SE; Kohane IS; Iosifescu DV; Smoller JW; Perlis RH
    BMJ; 2013 Jan; 346():f288. PubMed ID: 23360890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the risk of QT prolongation among SSRIs.
    Funk KA; Bostwick JR
    Ann Pharmacother; 2013 Oct; 47(10):1330-41. PubMed ID: 24259697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Citalopram and QT prolongation].
    Alušík Š; Paluch Z
    Vnitr Lek; 2018; 63(12):952-956. PubMed ID: 29334745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended Consequences of Adjusting Citalopram Prescriptions Following the 2011 FDA Warning.
    Gerlach LB; Kales HC; Maust DT; Chiang C; Stano C; Choe HM; Zivin K
    Am J Geriatr Psychiatry; 2017 Apr; 25(4):407-414. PubMed ID: 28012712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged QTc interval due to escitalopram overdose.
    Mohammed R; Norton J; Geraci SA; Newman DB; Koch CA
    J Miss State Med Assoc; 2010 Dec; 51(12):350-3. PubMed ID: 21370605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram, QTc Prolongation, and Torsades de Pointes.
    Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
    Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram, escitalopram, and the QT interval.
    Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
    [No Abstract]   [Full Text] [Related]  

  • 18. High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.
    Ray WA; Chung CP; Murray KT; Hall K; Stein CM
    J Clin Psychiatry; 2017 Feb; 78(2):190-195. PubMed ID: 27736049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug monitoring of a case of citalopram overdosage.
    Liotier J; Coudoré F
    Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical evaluation of the cardiac toxicity of citalopram: part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.